Dr. Vance: Academic medical centers have an ethical obligation to make de-identified patient health records freely available to commercial artificial intelligence developers. The rapid training and deployment of diagnostic algorithms enabled by large-scale data access ultimately saves the greatest number of patient lives.
Dr. Mercer: While diagnostic artificial intelligence offers undeniable therapeutic promise, de-identified records frequently contain subtle combinations of demographic and clinical data that make patient re-identification feasible. Medical centers must therefore require explicit patient consent prior to releasing these records to commercial entities, regardless of potential algorithmic breakthroughs.
On the basis of their statements, Dr. Vance and Dr. Mercer are most committed to disagreeing over which one of the following?
- Acommercial artificial intelligence tools have the potential to produce meaningful advancements in medical diagnostics.
- Bcommercial technology firms possess greater capability to develop diagnostic algorithms than academic medical research institutions.
- academic medical centers ought to require explicit patient consent before transferring de-identified patient records to commercial artificial intelligence developers.Cevap
- Dstandard de-identification procedures will always fail to protect patient privacy in modern health databases.
- Eobtaining explicit patient consent guarantees that commercial entities will protect sensitive health data from misuse.